{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:17:22Z","timestamp":1780057042812,"version":"3.54.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ejim.2010.02.009","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T08:44:05Z","timestamp":1269506645000},"page":"208-215","source":"Crossref","is-referenced-by-count":23,"title":["Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)"],"prefix":"10.1016","volume":"21","author":[{"given":"Tim","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hoppe-Lotichius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuk","family":"Tripkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Barreiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Wehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Biesterfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Schuchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2010.02.009_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ejim.2010.02.009_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00004836-200305000-00016","article-title":"Malignancy after liver transplantation in patients with premalignant conditions","volume":"36","author":"Menachem","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejim.2010.02.009_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.510310340","article-title":"Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation","volume":"31","author":"Zein","year":"2000","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ejim.2010.02.009_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-200210270-00008","article-title":"Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients","volume":"74","author":"Duvoux","year":"2002","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ejim.2010.02.009_bib5","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.V98.5.1332","article-title":"Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants","volume":"98","author":"Lemoine","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejim.2010.02.009_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","article-title":"Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience","volume":"236","author":"Jain","year":"2002","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejim.2010.02.009_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhep.2005.10.008","article-title":"Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?","volume":"44","author":"Aucejo","year":"2006","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2010.02.009_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-200210270-00007","article-title":"Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome","volume":"74","author":"Dotti","year":"2002","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ejim.2010.02.009_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ejim.2010.02.009_bib10","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","article-title":"Posttransplant lymphoproliferative disorders not associated with Epstein\u2013Barr virus: a distinct entity?","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"issue":"7820","key":"10.1016\/j.ejim.2010.02.009_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(73)93256-X","article-title":"Risk of cancer in renal-transplant recipients","volume":"2","author":"Hoover","year":"1973","journal-title":"Lancet"},{"issue":"6203","key":"10.1016\/j.ejim.2010.02.009_bib12","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.2.6203.1461","article-title":"Collaborative United Kingdom\u2013Australasian study of cancer in patients treated with immunosuppressive drugs","volume":"2","author":"Kinlen","year":"1979","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.ejim.2010.02.009_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.47.4.514","article-title":"Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low","volume":"47","author":"Farrell","year":"2000","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ejim.2010.02.009_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1055-9965.EPI-06-1070","article-title":"Altered immunity as a risk factor for non-Hodgkin lymphoma","volume":"16","author":"Grulich","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.ejim.2010.02.009_bib15","first-page":"161","article-title":"Cancer incidence in 13811 patients skin tested for allergy","volume":"15","author":"Eriksson","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.ejim.2010.02.009_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ejim.2010.02.009_bib17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/TP.0b013e31818fff64","article-title":"Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation","volume":"86","author":"Becker","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ejim.2010.02.009_bib18","first-page":"8","article-title":"Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop","volume":"14","author":"Harris","year":"1997","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.ejim.2010.02.009_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jnnp.72.2.230","article-title":"Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)","volume":"72","author":"Gabriel","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ejim.2010.02.009_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/lt.21152","article-title":"Posttransplantation lymphoproliferative disorder \u2014 the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein\u2013Barr virus","volume":"13","author":"Koch","year":"2007","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.ejim.2010.02.009_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/01.TP.0000057244.03192.BD","article-title":"Determination of risk factors for Epstein\u2013Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment","volume":"75","author":"Guthery","year":"2003","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ejim.2010.02.009_bib22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ejim.2010.02.009_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/01.tp.0000169035.10572.c6","article-title":"Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil","volume":"80","author":"Funch","year":"2005","journal-title":"Transplantation"},{"issue":"5 Pt 1","key":"10.1016\/j.ejim.2010.02.009_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"1\u20132","key":"10.1016\/j.ejim.2010.02.009_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10428199909145954","article-title":"Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group","volume":"36","author":"Shpilberg","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.ejim.2010.02.009_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10620-007-9908-z","article-title":"Is there any association between non-Hodgkin's lymphoma and primary sclerosing cholangitis\/autoimmune hepatitis overlap syndrome?","volume":"53","author":"Cholongitas","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.ejim.2010.02.009_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","article-title":"Malignant lymphoma-associated autoimmune diseases \u2014 a descriptive epidemiological study","volume":"22","author":"Varoczy","year":"2002","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.ejim.2010.02.009_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2008.08.022","article-title":"Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients","volume":"50","author":"Werner","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2010.02.009_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejim.2010.02.009_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"15","author":"Teufel","year":"2009","journal-title":"World J Gastroenterol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T16:08:50Z","timestamp":1558973330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620510000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0953620510000427"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2010.02.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}